ArticleMedicine2026
Androgen insensitivity syndrome: A case report.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
rationale46, XY disorder of sex development (46, XY DSD) is relatively rare and frequently missed in clinical practice, necessitating early standardized diagnosis and treatment. Androgen insensitivity syndrome (AIS), a major subtype, should be considered in phenotypic females with suggestive clinical clues. PATIENT CONCERNS: A 29-year-old phenotypic female presented with primary amenorrhea and intermittent abdominal pain. Examination revealed normal breast development, sparse pubic hair, and female external genitalia. Pelvic ultrasonography and CT showed an absent uterus and ovaries, with bilateral inguinal masses. DIAGNOSES: The case met the 3 diagnostic criteria for 46, XY DSD: 46,XY karyotype, testicular tissue, and feminized external genitalia. A diagnosis clinically consistent with complete AIS was further supported by the characteristic phenotype - female appearance, normal breast development, sparse pubic hair, and absent Müllerian structures. Other etiologies of undervirilization, including 5α-reductase deficiency and 17β-hydroxysteroid dehydrogenase deficiency, were considered. Genetic confirmation was unavailable, limiting subtype certainty.
interventionsFollowing counseling, the patient underwent laparoscopic bilateral orchiectomy as prophylactic gonadectomy to reduce malignancy risk, together with inguinal hernia repair, followed by postoperative hormone replacement therapy. Postoperative histopathology confirmed testicular tissue with Leydig cell hyperplasia, absent spermatogenic cells, and no malignancy. OUTCOMES: Abdominal pain resolved postoperatively, with improved psychological well-being and adaptation to the diagnosis under ongoing endocrine and psychological support. LESSONS: 46, XY DSD is underdiagnosed due to phenotypic variability, reliance on specialized tests, and social biases. AIS should be considered in the differential diagnosis of phenotypic females presenting with primary amenorrhea, developed secondary sexual characteristics, and an absent uterus on ultrasound. However, definitive subtyping requires AR gene sequencing, which was not available in this case. Early diagnosis requires careful assessment of newborn external genitalia, with specialist evaluation prompted by any atypical findings, and hormonal and genetic testing in adolescents with abnormal development. Multidisciplinary care - involving gynecologists, endocrinologists, surgeons, geneticists, and mental-health professionals - is essential for comprehensive management, including psychological support, hormone therapy, and timely prophylactic gonadectomy. Establishing specialized multidisciplinary centers for DSD is also recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.